This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2021 Feb;22(2):e42.

doi: 10.1016/S1470-2045(21)00023-1.

Correction to Lancet Oncol 2020; 21: e575-88

No authors listed

PMID: 33539751
DOI: 10.1016/S1470-2045(21)00023-1

Published Erratum

Correction to Lancet Oncol 2020; 21: e575-88

No authors listed. Lancet Oncol. 2021 Feb.

. 2021 Feb;22(2):e42.

doi: 10.1016/S1470-2045(21)00023-1.

PMID: 33539751
DOI: 10.1016/S1470-2045(21)00023-1

No abstract available

PubMed Disclaimer

Erratum for

Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.
Bennett CL, Schoen MW, Hoque S, Witherspoon BJ, Aboulafia DM, Hwang CS, Ray P, Yarnold PR, Chen BK, Schooley B, Taylor MA, Wyatt MD, Hrushesky WJ, Yang YT. Bennett CL, et al. Lancet Oncol. 2020 Dec;21(12):e575-e588. doi: 10.1016/S1470-2045(20)30485-X. Lancet Oncol. 2020. PMID: 33271114 Free PMC article. Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations